| 製品名 |
Lomefloxacin aspartate |
| 英語名 |
Lomefloxacin aspartate; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-Methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid L-Aspartate; 1-Ethyl-6,8-difluoro-7-(3-Methyl-1-piperazinyl)-4-oxo-1,4 -dihydro-3-quinoline carboxylic Acid L-Aspartate; DM 10 L-Aspartate; SC 47111A L-Aspartate; (S)-2-Aminosuccinic acid 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (1:1); Lomefloxacin, aspartate; Lomefloxacin aspartate |
| 分子式 |
C21H26F2N4O7 |
| 分子量 |
484.45 |
| InChI |
InChI=1S/C17H19F2N3O3.C4H7NO4/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22;5-2(4(8)9)1-3(6)7/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25);2H,1,5H2,(H,6,7)(H,8,9)/t;2-/m.0/s1 |
| CAS登録番号 |
211690-33-4 |
| 分子構造 |
|
| ハザードシンボル |
|
| リスクコード |
|
| 安全説明 |
|
|
JP
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
KR
MY
NL
NO
PL
PT
RU
SA
TR
